期刊文献+

托拉塞米与呋塞米治疗老年慢性心力衰竭伴利尿剂抵抗的短期疗效观察 被引量:11

Short-term efficacy observation on torasemide and furosemide treating diuretic resistance in elderly patients with chronic heart failure
原文传递
导出
摘要 目的:观察老年慢性心力衰竭伴利尿剂抵抗患者短期应用托拉塞米、呋塞米对利尿剂抵抗的临床疗效。方法:随机将60例老年慢性心力衰竭伴利尿剂抵抗患者分为呋塞米泵入组(A组,30例)和托拉塞米静推组(B组,30例),治疗5天,比较2组治疗前后血pro-BNP(Pro-Brain Natriuretic Peptide,pro-BNP)、6分钟步行试验、NYHA心功能分级、血电解质变化、尿量、肾功能等指标。结果:2组治疗后心功能均得到改善,尿量均明显增多,托拉塞米组疗效优于呋塞米组,差异有统计学意义(P<0.05);托拉塞米组(B组)6分钟步行试验较呋塞米组(A组)显著增加,pro-BNP则显著降低,差异均有统计学意义(P<0.05);A组治疗后血钾较治疗前降低,差异有统计学意义(P<0.05),B组血钾无明显改变(P>0.05),2组治疗前后血钠、血肌酐均无明显变化(P>0.05)。结论:短期泵入呋塞米和静推托拉塞米均可改善老年慢性心力衰竭伴利尿剂抵抗患者的临床症状,增加尿量,改善心功能,托拉塞米改善心功能总有效率高于呋塞米。 Objective:To investigate the short- term efficacy observation on torasemide and furosemide treating diuretic resistance in elderly patients with chronic heart failure. Methods: Sixty cases with chronic heart failure with diuretic resistance were divided into two groups : pump into furosemide group ( A group, n = 30) and torasemide injection group ( B group, n = 30). Pro - Brain Natriuretic Peptide ( pro - BNP) ,6 minutes walking test,heart function classification,blood electrolyte,urine output and kidney function were measured before and five days after treatment respectively. Results: By the end of five days therapy, heart function and urine output cf all patients were bet- ter than before; Heart function and urine output in torasemide injection group were significantly better compared with pump into furosemide group ( P 〈 0.05) ; 6 minutes walking test was significantly increased in torasemide injection group compared with pump into furosemide group ; pro - BNP was significantly decreased in torasemide injection group compared with pump into furosemide group( P 〈 0.05 ) ; serumpotassium was significantly decreased in pump into furosemide group compared with torasemide injection group, no significant difference in serum sodium and serum creatinine were observed in two groups. Conclusion:Short -term pump into furosemide and torasemide injection can improve the clinical symptoms in elderly patients with chronic heart failure with diuretic resistance, to increase urine output and im- prove heart function, torasemide to improve heart failure there is always more efficient than furosemide.
出处 《中国伤残医学》 2013年第10期33-35,共3页 Chinese Journal of Trauma and Disability Medicine
关键词 老年慢性心力衰竭 利尿剂抵抗 呋塞米 托拉塞米 Elderly with chronic heart failure Diuretic resistance Furosemide Torasemide
  • 相关文献

参考文献8

二级参考文献42

  • 1刘惠侠.长效袢利尿药托拉塞米临床研究进展[J].世界临床药物,2004,25(8):495-498. 被引量:11
  • 2杨帆,赖沙毅.充血性心力衰竭患者利尿剂抵抗[J].医学综述,2006,12(16):999-1000. 被引量:16
  • 3张福康.托拉塞米的临床应用与评价[J].中国新药杂志,2006,15(20):1787-1789. 被引量:12
  • 4Kramer BK,Schweda F, Riegger GA. Diuretic treatment and diuretic resistance in heart failure[J]. Am J Med, 1999,106( 1 ) : 90 -96.
  • 5Wakelkamp M, Alvan G, Gabrielsson J, et al. Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration[ J ]. Clin Pharrnacol Ther, 1996,60( 1 ) : 75 - 88.
  • 6Neuberg GW, Miller AB, O'Connor CM, et al. Diuretic resistance predicts mortality in patients with advanced heart failure[J]. Am Heart J,2002,144(1) :31 - 38.
  • 7Brater DC. Pharmacokinetlcs of loop diuretics in congestive hear failure[J]. Br Heart J, 1994,72(2 Suppl) :S4043.
  • 8Debruyne. Mechanisms and management of diuretic resistance in congestive heart failure[J]. Postgrad Med J ,2003,79(931 ):268- 271.
  • 9Lamb ED. Top 200 prescription drugs of 2OOS[EB/OL]. http://www.pharmacytimes.com/issue/pharmacy/2009/ 2009-05/RxFocusTop200Drugs-0509. 2009-05-15.
  • 10Food and Drug Administration. FDA approved drug products[EB/OL], http://www.accessdata.fda.gov/scripts/cder/ drug satfda/index.cfm. 2009-03-07.

共引文献134

同被引文献98

引证文献11

二级引证文献148

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部